Delivery Order SPE2DB20D3104-SPE2DB25FW0J7
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $1,113.80 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humalog insulin vials. The contract has a ceiling value of $1,077.00 and a completion date of April 2, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 unit/mL vial, a prescription insulin medication, with a ceiling value of $1,366.20 and a period of performance through September 2024. This delivery order is likely issued under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Insulin Lispro 100 Unit/ML pens (3ML) with a ceiling value of $1,358.28. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $5,887.90. This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-compete, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,811.89 contract is for the provision of 4,564,668,967 units of Humalog 100 Unit/mL insulin vials. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to deliver a range of pharmaceutical products and medical supplies to...